Stanford University
Showing 20,961-20,980 of 36,182 Results
-
Amelia Meyer
Academic Prog Prof 1, Pediatrics - Infectious Diseases
Current Role at StanfordResearch Program Manager
-
Everett Meyer
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy), of Pediatrics (Stem Cell Transplantation) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Inger Hultgren Meyer
Sr. Industrial Contracts Officer, Office of Technology Licensing (OTL)
BioInger is a Senior Industrial Contracts Officer in the Industrial Contracts Office within Stanford’s Office of Technology Licensing. She has over 14 years of experience as a lawyer at law firms and companies in the technology, health care, and consumer products industries in the U.S. and Europe. Before joining Stanford, Inger was an Associate General Counsel at Meta Platforms, Inc. where she advised Meta’s research and engineering teams on IP and other issues arising out of academic collaborations and drafted and negotiated a variety of complex academic collaboration agreements with university partners. Inger holds a B.A. in Government from Cornell University and a J.D. from George Washington University Law School.
-
Jeannie Meyer
Associate Director of Events, School of Engineering - External Relations
Current Role at StanfordPlan and coordinate donor relations, alumni relations and student outreach activities for the Dean's office in the School of Engineering.
-
Richard Meyer
Robert and Ruth Halperin Professor of Art History
BioAreas of Specialization:
20th-century American art and visual culture -
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
